{"transactions":[{"id":688024,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-08-13T20:22:00.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":146403,"price":17.51,"value":2563516.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.40 to $17.67 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in the footnote."}],"balance_after":253390,"source":{"system":"sec-edgar","filing":"0001628280-26-056757","document":"wk-form4_1786652518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056757/wk-form4_1786652518.xml","form_type":"4"}},{"id":858572,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":35880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":71760,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35880},"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858571,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":366972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":366972},"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858570,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":23544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 94,178 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 94,178 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":70634,"derivative":{"underlying":"Class A Common Stock","underlying_shares":23544},"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858569,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":45871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 183,486 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 183,486 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":45872,"derivative":{"underlying":"Class A Common Stock","underlying_shares":45871},"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858568,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":36232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":36232},"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858567,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":17976,"price":13.3,"value":239080.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":399793,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858566,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":35880,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":417769,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858565,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":183853,"price":13.31,"value":2447083.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":381889,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858564,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":366972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":565742,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858563,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":11796,"price":13.31,"value":157004.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":198770,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858562,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":23544,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":210566,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858561,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":22982,"price":13.31,"value":305890.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":187022,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858560,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":45871,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":210004,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858559,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":18502,"price":13.31,"value":246261.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":164133,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":858558,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:30:38.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":36232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":182635,"source":{"system":"sec-edgar","filing":"0001628280-26-015235","document":"wk-form4_1772746235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015235/wk-form4_1772746235.xml","form_type":"4"}},{"id":867537,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-03T21:28:37.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":65359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a performance-based restricted stock unit grant of 65,359 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents a performance-based restricted stock unit grant of 65,359 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."}],"balance_after":65359,"derivative":{"underlying":"Class A Common Stock","underlying_shares":65359},"source":{"system":"sec-edgar","filing":"0001628280-26-013890","document":"wk-form4_1772573314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026013890/wk-form4_1772573314.xml","form_type":"4"}},{"id":867536,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T21:28:37.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":65359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 2, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 2, 2027."}],"balance_after":65359,"derivative":{"underlying":"Class A Common Stock","underlying_shares":65359},"source":{"system":"sec-edgar","filing":"0001628280-26-013890","document":"wk-form4_1772573314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026013890/wk-form4_1772573314.xml","form_type":"4"}},{"id":998916,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-14T22:13:51.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":false,"shares":95525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.75,"expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":95525},"source":{"system":"sec-edgar","filing":"0001628280-25-052413","document":"wk-form4_1763158428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025052413/wk-form4_1763158428.xml","form_type":"4"}},{"id":998915,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-14T22:13:51.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":false,"shares":36331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.75,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":36331},"source":{"system":"sec-edgar","filing":"0001628280-25-052413","document":"wk-form4_1763158428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025052413/wk-form4_1763158428.xml","form_type":"4"}},{"id":998914,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-11-14T22:13:51.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":131856,"price":11.92,"value":1571723.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $11.85 to $12.02 per share, inclusive.  The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":146403,"source":{"system":"sec-edgar","filing":"0001628280-25-052413","document":"wk-form4_1763158428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025052413/wk-form4_1763158428.xml","form_type":"4"}},{"id":998913,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-11-14T22:13:51.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":true,"shares":95525,"price":2.75,"value":262693.75,"ownership":{"direct":true},"balance_after":278259,"source":{"system":"sec-edgar","filing":"0001628280-25-052413","document":"wk-form4_1763158428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025052413/wk-form4_1763158428.xml","form_type":"4"}},{"id":998912,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-11-14T22:13:51.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":true,"shares":36331,"price":2.75,"value":99910.25,"ownership":{"direct":true},"balance_after":182734,"source":{"system":"sec-edgar","filing":"0001628280-25-052413","document":"wk-form4_1763158428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025052413/wk-form4_1763158428.xml","form_type":"4"}},{"id":1056841,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-08-25T20:27:31.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":6340,"price":9.5,"value":60230.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.51 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in this footnote."}],"balance_after":146403,"source":{"system":"sec-edgar","filing":"0001738061-25-000004","document":"wk-form4_1756153648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000173806125000004/wk-form4_1756153648.xml","form_type":"4"}},{"id":1056840,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-08-25T20:27:31.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":114492,"price":9.66,"value":1105992.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.60 to $9.75 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in this footnote."}],"balance_after":152743,"source":{"system":"sec-edgar","filing":"0001738061-25-000004","document":"wk-form4_1756153648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000173806125000004/wk-form4_1756153648.xml","form_type":"4"}},{"id":1065379,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-08-15T20:31:52.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":71694,"price":9.29,"value":666037.26,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.16 to $9.41 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":267235,"source":{"system":"sec-edgar","filing":"0001723128-25-000052","document":"wk-form4_1755289907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312825000052/wk-form4_1755289907.xml","form_type":"4"}},{"id":1067824,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-08-13T20:40:37.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":9.04,"value":452000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.03 to $9.07 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in this footnote."}],"balance_after":338929,"source":{"system":"sec-edgar","filing":"0001723128-25-000050","document":"wk-form4_1755117633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312825000050/wk-form4_1755117633.xml","form_type":"4"}},{"id":1142779,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-05-19T20:16:23.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":49140,"price":7.58,"value":372481.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.48 to $7.63 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in this footnote."}],"balance_after":388929,"source":{"system":"sec-edgar","filing":"0001628280-25-026513","document":"wk-form4_1747685776.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025026513/wk-form4_1747685776.xml","form_type":"4"}},{"id":1222569,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":35879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"On March 4, 2024, the Reporting Person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"On March 4, 2024, the Reporting Person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":107640,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35879},"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222568,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":94178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2026."}],"balance_after":94178,"derivative":{"underlying":"Class A Common Stock","underlying_shares":94178},"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222567,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":188356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Represents a performance-based restricted stock unit grant of 94,178 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units will be deemed earned and vested when settled into shares of Class A Common Stock shortly after February 28, 2028, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Represents a performance-based restricted stock unit grant of 94,178 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units will be deemed earned and vested when settled into shares of Class A Common Stock shortly after February 28, 2028, the last day of the performance period."}],"balance_after":188356,"derivative":{"underlying":"Class A Common Stock","underlying_shares":188356},"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222566,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":144928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":144928},"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222565,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":45872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 183,486 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 183,486 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":91743,"derivative":{"underlying":"Class A Common Stock","underlying_shares":45872},"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222564,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":36232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":36232,"derivative":{"underlying":"Class A Common Stock","underlying_shares":36232},"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222563,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":18353,"price":8.84,"value":162240.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":438069,"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222562,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":35879,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":456422,"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222561,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":74131,"price":8.76,"value":649387.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":420543,"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222560,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":144928,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":494674,"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222559,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":23464,"price":8.76,"value":205544.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":349746,"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222558,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":45872,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":373210,"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222557,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":18533,"price":8.76,"value":162349.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":327338,"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1222556,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:11:32.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":36232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":345871,"source":{"system":"sec-edgar","filing":"0001628280-25-010678","document":"wk-form4_1741219884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010678/wk-form4_1741219884.xml","form_type":"4"}},{"id":1228776,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T23:58:01.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":28958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal payments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal payments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":28958},"source":{"system":"sec-edgar","filing":"0001628280-25-010113","document":"wk-form4_1741132675.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010113/wk-form4_1741132675.xml","form_type":"4"}},{"id":1228775,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:58:01.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":10985,"price":8.67,"value":95239.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":309639,"source":{"system":"sec-edgar","filing":"0001628280-25-010113","document":"wk-form4_1741132675.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010113/wk-form4_1741132675.xml","form_type":"4"}},{"id":1228774,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:58:01.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":28958,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":320624,"source":{"system":"sec-edgar","filing":"0001628280-25-010113","document":"wk-form4_1741132675.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010113/wk-form4_1741132675.xml","form_type":"4"}},{"id":1431397,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-08-16T20:17:39.000Z","date":"2024-08-14","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":7.75,"value":775000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $7.66 to $7.84 per share, inclusive.  The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":291666,"source":{"system":"sec-edgar","filing":"0001628280-24-037557","document":"wk-form4_1723839453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024037557/wk-form4_1723839453.xml","form_type":"4"}},{"id":1596626,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":287038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Represents a performance-based restricted stock unit grant of 143,519 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period.  The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2027, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Represents a performance-based restricted stock unit grant of 143,519 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period.  The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2027, the last day of the performance period."}],"balance_after":287038,"derivative":{"underlying":"Class A Common Stock","underlying_shares":287038},"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596625,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":143519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vest in four equal installments beginning on March 4, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vest in four equal installments beginning on March 4, 2025."}],"balance_after":143519,"derivative":{"underlying":"Class A Common Stock","underlying_shares":143519},"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596624,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":false,"shares":45871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2023, the reporting person was granted 183,486 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2023, the reporting person was granted 183,486 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":137615,"derivative":{"underlying":"Class A Common Stock","underlying_shares":45871},"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596623,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":false,"shares":36232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":72464,"derivative":{"underlying":"Class A Common Stock","underlying_shares":36232},"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596622,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":false,"shares":28957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":28958,"derivative":{"underlying":"Class A Common Stock","underlying_shares":28957},"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596621,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":22982,"price":5.47,"value":125711.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":391666,"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596620,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":true,"shares":45871,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":414648,"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596619,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":18153,"price":5.47,"value":99296.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":368777,"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596618,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":true,"shares":36232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":386930,"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596617,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":15181,"price":5.47,"value":83040.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":350698,"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1596616,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:35:17.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":true,"shares":28957,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":365879,"source":{"system":"sec-edgar","filing":"0001628280-24-008945","document":"wk-form4_1709674499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008945/wk-form4_1709674499.xml","form_type":"4"}},{"id":1610089,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-02-29T21:25:51.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":false,"shares":35620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 142,480  restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 142,480  restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35620},"source":{"system":"sec-edgar","filing":"0001628280-24-007994","document":"wk-form4_1709241939.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024007994/wk-form4_1709241939.xml","form_type":"4"}},{"id":1610088,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-02-29T21:25:51.000Z","date":"2024-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":18670,"price":5.71,"value":106605.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":336922,"source":{"system":"sec-edgar","filing":"0001628280-24-007994","document":"wk-form4_1709241939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024007994/wk-form4_1709241939.xml","form_type":"4"}},{"id":1610087,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-02-29T21:25:51.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":true,"shares":35620,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":355592,"source":{"system":"sec-edgar","filing":"0001628280-24-007994","document":"wk-form4_1709241939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024007994/wk-form4_1709241939.xml","form_type":"4"}},{"id":1966094,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-03-07T23:00:56.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":366972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents a performance-based restricted stock unit grant of 183,486 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents a performance-based restricted stock unit grant of 183,486 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Represents a performance-based restricted stock unit grant of 183,486 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Represents a performance-based restricted stock unit grant of 183,486 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Represents a performance-based restricted stock unit grant of 183,486 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."}],"balance_after":366972,"derivative":{"underlying":"Class A Common Stock","underlying_shares":366972},"source":{"system":"sec-edgar","filing":"0001209191-23-016934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016934/doc4.xml","form_type":"4"}},{"id":1966093,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-07T23:00:56.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":183486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2024."}],"balance_after":183486,"derivative":{"underlying":"Class A Common Stock","underlying_shares":183486},"source":{"system":"sec-edgar","filing":"0001209191-23-016934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016934/doc4.xml","form_type":"4"}},{"id":1966092,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-07T23:00:56.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":36232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":108696,"derivative":{"underlying":"Class A Common Stock","underlying_shares":36232},"source":{"system":"sec-edgar","filing":"0001209191-23-016934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016934/doc4.xml","form_type":"4"}},{"id":1966091,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-07T23:00:56.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":18064,"price":1.92,"value":34682.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":319972,"source":{"system":"sec-edgar","filing":"0001209191-23-016934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016934/doc4.xml","form_type":"4"}},{"id":1966090,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-07T23:00:56.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":36232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":338036,"source":{"system":"sec-edgar","filing":"0001209191-23-016934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016934/doc4.xml","form_type":"4"}},{"id":1973928,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-03T21:31:09.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":28958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":57915,"derivative":{"underlying":"Class A Common Stock","underlying_shares":28958},"source":{"system":"sec-edgar","filing":"0001209191-23-015519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015519/doc4.xml","form_type":"4"}},{"id":1973927,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-03T21:31:09.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":11729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 46,914 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 46,914 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":11729},"source":{"system":"sec-edgar","filing":"0001209191-23-015519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015519/doc4.xml","form_type":"4"}},{"id":1973926,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-03T21:31:09.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":15555,"price":2.09,"value":32509.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":301804,"source":{"system":"sec-edgar","filing":"0001209191-23-015519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015519/doc4.xml","form_type":"4"}},{"id":1973925,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-03T21:31:09.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":28958,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":317359,"source":{"system":"sec-edgar","filing":"0001209191-23-015519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015519/doc4.xml","form_type":"4"}},{"id":1973924,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-03T21:31:09.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":6504,"price":2.09,"value":13593.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":288401,"source":{"system":"sec-edgar","filing":"0001209191-23-015519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015519/doc4.xml","form_type":"4"}},{"id":1973923,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-03T21:31:09.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":11729,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":294905,"source":{"system":"sec-edgar","filing":"0001209191-23-015519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015519/doc4.xml","form_type":"4"}},{"id":1983835,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-01T21:30:50.000Z","date":"2023-02-27","kind":"exercise","acquired":false,"shares":35620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 142,480 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 142,480 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":35620,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35620},"source":{"system":"sec-edgar","filing":"0001209191-23-014120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123014120/doc4.xml","form_type":"4"}},{"id":1983834,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-01T21:30:50.000Z","date":"2023-02-27","kind":"tax_withholding","acquired":false,"shares":19752,"price":2.16,"value":42664.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":283176,"source":{"system":"sec-edgar","filing":"0001209191-23-014120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123014120/doc4.xml","form_type":"4"}},{"id":1983833,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-01T21:30:50.000Z","date":"2023-02-27","kind":"exercise","acquired":true,"shares":35620,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":302928,"source":{"system":"sec-edgar","filing":"0001209191-23-014120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123014120/doc4.xml","form_type":"4"}},{"id":2276250,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-05-10T22:57:20.000Z","date":"2022-05-07","kind":"exercise","acquired":false,"shares":4442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4442},"source":{"system":"sec-edgar","filing":"0001209191-22-028163","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028163/doc4.xml","form_type":"4"}},{"id":2276249,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-05-10T22:57:20.000Z","date":"2022-05-07","kind":"tax_withholding","acquired":false,"shares":2228,"price":3.4,"value":7575.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":267308,"source":{"system":"sec-edgar","filing":"0001209191-22-028163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028163/doc4.xml","form_type":"4"}},{"id":2276248,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-05-10T22:57:20.000Z","date":"2022-05-07","kind":"exercise","acquired":true,"shares":4442,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":269536,"source":{"system":"sec-edgar","filing":"0001209191-22-028163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028163/doc4.xml","form_type":"4"}},{"id":2354830,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-03-04T02:21:07.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":289856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."}],"balance_after":289856,"derivative":{"underlying":"Class A Common Stock","underlying_shares":289856},"source":{"system":"sec-edgar","filing":"0001209191-22-016055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016055/doc4.xml","form_type":"4"}},{"id":2354829,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T02:21:07.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":144928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2023."}],"balance_after":144928,"derivative":{"underlying":"Class A Common Stock","underlying_shares":144928},"source":{"system":"sec-edgar","filing":"0001209191-22-016055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016055/doc4.xml","form_type":"4"}},{"id":2354828,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T02:21:07.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":28957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":86873,"derivative":{"underlying":"Class A Common Stock","underlying_shares":28957},"source":{"system":"sec-edgar","filing":"0001209191-22-016055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016055/doc4.xml","form_type":"4"}},{"id":2354827,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T02:21:07.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":11728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 46,914 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 46,914 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":11729,"derivative":{"underlying":"Class A Common Stock","underlying_shares":11728},"source":{"system":"sec-edgar","filing":"0001209191-22-016055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016055/doc4.xml","form_type":"4"}},{"id":2354826,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:21:07.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":8905,"price":4.45,"value":39627.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":265094,"source":{"system":"sec-edgar","filing":"0001209191-22-016055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016055/doc4.xml","form_type":"4"}},{"id":2354825,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:21:07.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":28957,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":273999,"source":{"system":"sec-edgar","filing":"0001209191-22-016055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016055/doc4.xml","form_type":"4"}},{"id":2354824,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:21:07.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":3607,"price":4.45,"value":16051.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":245042,"source":{"system":"sec-edgar","filing":"0001209191-22-016055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016055/doc4.xml","form_type":"4"}},{"id":2354823,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:21:07.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":11728,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":248649,"source":{"system":"sec-edgar","filing":"0001209191-22-016055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016055/doc4.xml","form_type":"4"}},{"id":2365566,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-01T22:11:00.000Z","date":"2022-02-27","kind":"exercise","acquired":false,"shares":35620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 142,480 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 142,480 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":71240,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35620},"source":{"system":"sec-edgar","filing":"0001209191-22-014142","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122014142/doc4.xml","form_type":"4"}},{"id":2365565,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-01T22:11:00.000Z","date":"2022-02-27","kind":"tax_withholding","acquired":false,"shares":11695,"price":4.59,"value":53680.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":236921,"source":{"system":"sec-edgar","filing":"0001209191-22-014142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122014142/doc4.xml","form_type":"4"}},{"id":2365564,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-01T22:11:00.000Z","date":"2022-02-27","kind":"exercise","acquired":true,"shares":35620,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":248616,"source":{"system":"sec-edgar","filing":"0001209191-22-014142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122014142/doc4.xml","form_type":"4"}},{"id":2466368,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-12-17T21:15:08.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":2000,"price":3.95,"value":7900.0,"ownership":{"direct":true},"balance_after":212996,"source":{"system":"sec-edgar","filing":"0001209191-21-070257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121070257/doc4.xml","form_type":"4"}},{"id":2718728,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-05-11T18:55:17.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":4441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":4442,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4441},"source":{"system":"sec-edgar","filing":"0001209191-21-031566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121031566/doc4.xml","form_type":"4"}},{"id":2718727,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-05-11T18:55:17.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":1366,"price":5.2,"value":7103.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":214996,"source":{"system":"sec-edgar","filing":"0001209191-21-031566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121031566/doc4.xml","form_type":"4"}},{"id":2718726,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-05-11T18:55:17.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":4441,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":216362,"source":{"system":"sec-edgar","filing":"0001209191-21-031566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121031566/doc4.xml","form_type":"4"}},{"id":2782810,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T20:04:23.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":36330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on May 7, 2018 and the total award of 72,661 vests in four equal installments on May 7, 2019, May 7, 2020, May 7, 2021 and May 7, 2022."}],"balance_after":36331,"derivative":{"exercise_price":2.75,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":36330},"source":{"system":"sec-edgar","filing":"0001209191-21-021301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121021301/doc4.xml","form_type":"4"}},{"id":2782809,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-03-17T20:04:23.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":36330,"price":6.8673,"value":249489.009,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $6.86 to $6.88.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":211921,"source":{"system":"sec-edgar","filing":"0001209191-21-021301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121021301/doc4.xml","form_type":"4"}},{"id":2782808,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-03-17T20:04:23.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":36330,"price":2.75,"value":99907.5,"ownership":{"direct":true},"balance_after":248251,"source":{"system":"sec-edgar","filing":"0001209191-21-021301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121021301/doc4.xml","form_type":"4"}},{"id":2814138,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2021-03-03T22:05:32.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":231660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the maximum number of shares issuable under the performance-based restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"50% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. Additional performance-based restricted stock units are earned at higher levels and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10 (75%), $12 (100%), $14 (125%), $16 (150%), $18 (175%) and $20 (200%), respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 29,2024, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"50% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. Additional performance-based restricted stock units are earned at higher levels and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10 (75%), $12 (100%), $14 (125%), $16 (150%), $18 (175%) and $20 (200%), respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 29,2024, the last day of the performance period."}],"balance_after":231660,"derivative":{"underlying":"Class A Common Stock","underlying_shares":231660},"source":{"system":"sec-edgar","filing":"0001209191-21-016996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016996/doc4.xml","form_type":"4"}},{"id":2814137,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T22:05:32.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":115830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2022."}],"balance_after":115830,"derivative":{"underlying":"Class A Common Stock","underlying_shares":115830},"source":{"system":"sec-edgar","filing":"0001209191-21-016996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016996/doc4.xml","form_type":"4"}},{"id":2820582,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T21:38:57.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":11729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock units represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2019, the reporting person was granted 46,914 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 1, 2019, the reporting person was granted 46,914 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":23457,"derivative":{"underlying":"Class A Common Stock","underlying_shares":11729},"source":{"system":"sec-edgar","filing":"0001209191-21-016058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016058/doc4.xml","form_type":"4"}},{"id":2820581,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T21:38:57.000Z","date":"2021-02-27","kind":"exercise","acquired":false,"shares":35620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock units represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 142,480 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 142,480 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":106860,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35620},"source":{"system":"sec-edgar","filing":"0001209191-21-016058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016058/doc4.xml","form_type":"4"}},{"id":2820580,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:38:57.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":3607,"price":5.18,"value":18684.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":211921,"source":{"system":"sec-edgar","filing":"0001209191-21-016058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016058/doc4.xml","form_type":"4"}}],"next_cursor":"2021-03-02T21:38:57.000000Z,2820580"}